{
  "data": [
    {
      "id": "stat_TVS8NZ8FRH1ZBBSQJ144G7R723",
      "url": "https://statorigin.org/stat/stat_TVS8NZ8FRH1ZBBSQJ144G7R723",
      "indicator": {
        "slug": "new-active-substance-approvals",
        "name": "New active substance approvals",
        "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
      },
      "industry": [
        {
          "slug": "pharmaceuticals",
          "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
          "isic": "C21",
          "is_primary": true
        }
      ],
      "region": {
        "code": "EU",
        "name": "European Union",
        "type": "bloc"
      },
      "period": {
        "start": "2025-01-01",
        "end": "2025-12-31",
        "type": "year"
      },
      "value": 39,
      "value_text": "39",
      "unit": "count",
      "currency": null,
      "scale": "1",
      "value_type": "actual",
      "source": {
        "org": "Centre for Innovation in Regulatory Science",
        "org_short_name": "CIRS",
        "org_url": "https://cirsci.org",
        "org_tier": 3,
        "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
        "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
        "document_type": "press_release",
        "locator": "Key Findings",
        "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "self_reported": false
      },
      "verification": "verified",
      "verified_by": "seed:auto-extract-v1",
      "verified_at": "2026-09-17T16:36:08.269Z",
      "confidence": 0.9,
      "is_secondhand": false,
      "supersedes": null,
      "superseded_by": null,
      "is_current": true,
      "citation": {
        "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_TVS8NZ8FRH1ZBBSQJ144G7R723",
        "bibtex": "@misc{cirs2025activeg7r723,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_TVS8NZ8FRH1ZBBSQJ144G7R723},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
      },
      "updated_at": "2026-09-17T16:36:08.269Z"
    },
    {
      "id": "stat_AMV8QYAVFBPB1H3DYFVGJH21W6",
      "url": "https://statorigin.org/stat/stat_AMV8QYAVFBPB1H3DYFVGJH21W6",
      "indicator": {
        "slug": "new-active-substance-approvals",
        "name": "New active substance approvals",
        "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
      },
      "industry": [
        {
          "slug": "pharmaceuticals",
          "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
          "isic": "C21",
          "is_primary": true
        }
      ],
      "region": {
        "code": "AU",
        "name": "Australia",
        "type": "country"
      },
      "period": {
        "start": "2025-01-01",
        "end": "2025-12-31",
        "type": "year"
      },
      "value": 42,
      "value_text": "42",
      "unit": "count",
      "currency": null,
      "scale": "1",
      "value_type": "actual",
      "source": {
        "org": "Centre for Innovation in Regulatory Science",
        "org_short_name": "CIRS",
        "org_url": "https://cirsci.org",
        "org_tier": 3,
        "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
        "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
        "document_type": "press_release",
        "locator": "Key Findings",
        "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "self_reported": false
      },
      "verification": "verified",
      "verified_by": "seed:auto-extract-v1",
      "verified_at": "2026-09-17T16:36:08.269Z",
      "confidence": 0.9,
      "is_secondhand": false,
      "supersedes": null,
      "superseded_by": null,
      "is_current": true,
      "citation": {
        "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_AMV8QYAVFBPB1H3DYFVGJH21W6",
        "bibtex": "@misc{cirs2025activejh21w6,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_AMV8QYAVFBPB1H3DYFVGJH21W6},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
      },
      "updated_at": "2026-09-17T16:36:08.269Z"
    },
    {
      "id": "stat_YMXBXJ0P43KQAEPECM9ZVVQ029",
      "url": "https://statorigin.org/stat/stat_YMXBXJ0P43KQAEPECM9ZVVQ029",
      "indicator": {
        "slug": "new-active-substance-approvals",
        "name": "New active substance approvals",
        "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
      },
      "industry": [
        {
          "slug": "pharmaceuticals",
          "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
          "isic": "C21",
          "is_primary": true
        }
      ],
      "region": {
        "code": "CA",
        "name": "Canada",
        "type": "country"
      },
      "period": {
        "start": "2025-01-01",
        "end": "2025-12-31",
        "type": "year"
      },
      "value": 44,
      "value_text": "44",
      "unit": "count",
      "currency": null,
      "scale": "1",
      "value_type": "actual",
      "source": {
        "org": "Centre for Innovation in Regulatory Science",
        "org_short_name": "CIRS",
        "org_url": "https://cirsci.org",
        "org_tier": 3,
        "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
        "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
        "document_type": "press_release",
        "locator": "Key Findings",
        "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "self_reported": false
      },
      "verification": "verified",
      "verified_by": "seed:auto-extract-v1",
      "verified_at": "2026-09-17T07:16:01.811Z",
      "confidence": 0.9,
      "is_secondhand": false,
      "supersedes": null,
      "superseded_by": null,
      "is_current": true,
      "citation": {
        "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_YMXBXJ0P43KQAEPECM9ZVVQ029",
        "bibtex": "@misc{cirs2025activevvq029,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_YMXBXJ0P43KQAEPECM9ZVVQ029},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
      },
      "updated_at": "2026-09-17T07:16:01.811Z"
    },
    {
      "id": "stat_84WCV23H6VE3N5JEVT5K316PE0",
      "url": "https://statorigin.org/stat/stat_84WCV23H6VE3N5JEVT5K316PE0",
      "indicator": {
        "slug": "new-active-substance-approvals",
        "name": "New active substance approvals",
        "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
      },
      "industry": [
        {
          "slug": "pharmaceuticals",
          "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
          "isic": "C21",
          "is_primary": true
        }
      ],
      "region": {
        "code": "JP",
        "name": "Japan",
        "type": "country"
      },
      "period": {
        "start": "2025-01-01",
        "end": "2025-12-31",
        "type": "year"
      },
      "value": 40,
      "value_text": "40",
      "unit": "count",
      "currency": null,
      "scale": "1",
      "value_type": "actual",
      "source": {
        "org": "Centre for Innovation in Regulatory Science",
        "org_short_name": "CIRS",
        "org_url": "https://cirsci.org",
        "org_tier": 3,
        "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
        "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
        "document_type": "press_release",
        "locator": "Key Findings",
        "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "self_reported": false
      },
      "verification": "verified",
      "verified_by": "seed:auto-extract-v1",
      "verified_at": "2026-09-17T16:36:08.269Z",
      "confidence": 0.9,
      "is_secondhand": false,
      "supersedes": null,
      "superseded_by": null,
      "is_current": true,
      "citation": {
        "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_84WCV23H6VE3N5JEVT5K316PE0",
        "bibtex": "@misc{cirs2025active316pe0,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_84WCV23H6VE3N5JEVT5K316PE0},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
      },
      "updated_at": "2026-09-17T16:36:08.269Z"
    },
    {
      "id": "stat_N08APVFSYJH011YV93A6FEWNP8",
      "url": "https://statorigin.org/stat/stat_N08APVFSYJH011YV93A6FEWNP8",
      "indicator": {
        "slug": "new-active-substance-approvals",
        "name": "New active substance approvals",
        "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
      },
      "industry": [
        {
          "slug": "pharmaceuticals",
          "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
          "isic": "C21",
          "is_primary": true
        }
      ],
      "region": {
        "code": "CH",
        "name": "Switzerland",
        "type": "country"
      },
      "period": {
        "start": "2025-01-01",
        "end": "2025-12-31",
        "type": "year"
      },
      "value": 34,
      "value_text": "34",
      "unit": "count",
      "currency": null,
      "scale": "1",
      "value_type": "actual",
      "source": {
        "org": "Centre for Innovation in Regulatory Science",
        "org_short_name": "CIRS",
        "org_url": "https://cirsci.org",
        "org_tier": 3,
        "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
        "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
        "document_type": "press_release",
        "locator": "Key Findings",
        "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "self_reported": false
      },
      "verification": "verified",
      "verified_by": "seed:auto-extract-v1",
      "verified_at": "2026-09-17T07:16:01.811Z",
      "confidence": 0.9,
      "is_secondhand": false,
      "supersedes": null,
      "superseded_by": null,
      "is_current": true,
      "citation": {
        "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_N08APVFSYJH011YV93A6FEWNP8",
        "bibtex": "@misc{cirs2025activefewnp8,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_N08APVFSYJH011YV93A6FEWNP8},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
      },
      "updated_at": "2026-09-17T07:16:01.811Z"
    },
    {
      "id": "stat_XXEFA32VWBN7VNBT9JADH6JBR2",
      "url": "https://statorigin.org/stat/stat_XXEFA32VWBN7VNBT9JADH6JBR2",
      "indicator": {
        "slug": "new-active-substance-approvals",
        "name": "New active substance approvals",
        "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
      },
      "industry": [
        {
          "slug": "pharmaceuticals",
          "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
          "isic": "C21",
          "is_primary": true
        }
      ],
      "region": {
        "code": "US",
        "name": "United States",
        "type": "country"
      },
      "period": {
        "start": "2025-01-01",
        "end": "2025-12-31",
        "type": "year"
      },
      "value": 50,
      "value_text": "50",
      "unit": "count",
      "currency": null,
      "scale": "1",
      "value_type": "actual",
      "source": {
        "org": "Centre for Innovation in Regulatory Science",
        "org_short_name": "CIRS",
        "org_url": "https://cirsci.org",
        "org_tier": 3,
        "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
        "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
        "document_type": "press_release",
        "locator": "Key Findings",
        "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "self_reported": false
      },
      "verification": "verified",
      "verified_by": "seed:auto-extract-v1",
      "verified_at": "2026-09-17T16:36:08.269Z",
      "confidence": 0.9,
      "is_secondhand": false,
      "supersedes": null,
      "superseded_by": null,
      "is_current": true,
      "citation": {
        "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_XXEFA32VWBN7VNBT9JADH6JBR2",
        "bibtex": "@misc{cirs2025activeh6jbr2,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_XXEFA32VWBN7VNBT9JADH6JBR2},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
      },
      "updated_at": "2026-09-17T16:36:08.269Z"
    }
  ],
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 6,
    "limit": 50,
    "next_cursor": null
  }
}